Tilray's Rescheduling Rally Keeps Fading -- Where Will the Stock Be if Washington Stalls Again?

The article discusses Tilray's stock performance following a rescheduling rally, noting that the upward momentum is fading and suggesting uncertainty about future stock movement if regulatory progress stalls. The headline implies a potential downside risk tied to Washington's actions or inaction.

• article states Tilray's rescheduling rally is fading
• article implies potential stall in Washington's regulatory actions

The article does not provide specific evidence of regulatory stalling or quantify its impact on Tilray's stock, but it suggests that Tilray (TLRY) may face downward pressure if regulatory developments do not proceed as expected. The transmission mechanism is indirect, relying on the assumption that regulatory progress drives Tilray's stock performance.